NVO: Novo Nordisk A/S Stocks News on November 23, 2024

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

NVO

Investor's Business Daily

11 hours ago

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl

NVO

Medical Device Network

16 hours ago

“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl

Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock

NVO

Zacks

16 hours ago

Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock

NVO

Investing.com

18 hours ago

Barclays says buy Novo Nordisk stock 'into this critically important catalyst'

Ozempic 2.0, the Oura ring's new trick, and RFK Jr. vs. vaccines: Pharma news roundup

NVO

Quartz

a day ago

Ozempic 2.0, the Oura ring's new trick, and RFK Jr. vs. vaccines: Pharma news roundup

The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.

NVO

Barrons.com

a day ago

The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.

PFE vs. NVO: Which Stock Is the Better Value Option?

NVO

Zacks

2 days ago

PFE vs. NVO: Which Stock Is the Better Value Option?

Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU

NVO

Zacks

2 days ago

Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop

NVO

Barrons.com

2 days ago

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop

Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound

NVO

Quartz

3 days ago

Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound

NVO

MT Newswires

3 days ago

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

NVO

MT Newswires

3 days ago

Update: Novo Nordisk Launches Weight-Loss Drug Wegovy in China

NVO

Motley Fool

3 days ago

Is Novo Nordisk Stock a Buy Right Now?

RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.

NVO

Barrons.com

3 days ago

RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.

NVO

MT Newswires

3 days ago

Sector Update: Health Care Stocks Decline

NVO

MT Newswires

4 days ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

NVO

MT Newswires

4 days ago

Sector Update: Health Care

NVO

MT Newswires

4 days ago

Novo Nordisk Reportedly Launches Weight-Loss Drug Wegovy in China

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

NVO

GlobeNewswire

4 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Novo Erases 2024 Gain, Wiping Out $210 Billion in Value

NVO

Bloomberg

4 days ago

Novo Erases 2024 Gain, Wiping Out $210 Billion in Value

NVO

MT Newswires

4 days ago

Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs

Employers Get Pressure to Pay for Drugs Like Wegovy

NVO

The Wall Street Journal

4 days ago

Employers Get Pressure to Pay for Drugs Like Wegovy

Makers of Weight-Loss Drugs Want Your Employer to Pay for Them

NVO

The Wall Street Journal

4 days ago

Makers of Weight-Loss Drugs Want Your Employer to Pay for Them

RFK Jr.'s HHS nomination sparks concern over pharma stocks

NVO

Yahoo Finance Video

4 days ago

RFK Jr.'s HHS nomination sparks concern over pharma stocks

How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health

NVO

Yahoo Finance

5 days ago

How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health

Novo Nordisk A/S - share repurchase programme

NVO

GlobeNewswire

5 days ago

Novo Nordisk A/S - share repurchase programme

NVO

MT Newswires

5 days ago

Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

NVO

Motley Fool

5 days ago

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs

NVO

Reuters

5 days ago

Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs

NVO

Morningstar Research

5 days ago

Analyst Report: Novo Nordisk A/S

The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?

NVO

Yahoo Finance

7 days ago

The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too

NVO

The Wall Street Journal

8 days ago

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too

Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter

NVO

Insider Monkey

8 days ago

Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter

NVO

The Wall Street Journal

8 days ago

RFK Jr. News Hits Global Pharma Stocks

Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate

NVO

Zacks

9 days ago

Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

NVO

Motley Fool

9 days ago

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

NVO

Investor's Business Daily

9 days ago

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal

NVO

Reuters

10 days ago

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal

NVO

Argus Research

10 days ago

Analyst Report: Novo Nordisk

NVO

GlobeNewswire

10 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision

NVO

Yahoo Finance

10 days ago

Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision

Novo Nordisk A/S (NVO): A Bull Case Theory

NVO

Insider Monkey

10 days ago

Novo Nordisk A/S (NVO): A Bull Case Theory

Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot

NVO

Investor's Business Daily

10 days ago

Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot

NVO

GlobeNewswire

11 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Here's Why Novo Nordisk (NVO) is a Strong Growth Stock

NVO

Zacks

11 days ago

Here's Why Novo Nordisk (NVO) is a Strong Growth Stock

Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?

NVO

Zacks

12 days ago

Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?

Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.

NVO

Barrons.com

12 days ago

Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.

Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

NVO

Motley Fool

13 days ago

Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

Is Viking Therapeutics a Buy on the Dip?

NVO

Motley Fool

13 days ago

Is Viking Therapeutics a Buy on the Dip?

NVO

GlobeNewswire

14 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

NVO

GlobeNewswire

14 days ago

Novo Nordisk A/S - share repurchase programme

Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme

NVO

GlobeNewswire

14 days ago

Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme

Investors Like Certainty. Trump's Win Gave Them Some.

NVO

Motley Fool

15 days ago

Investors Like Certainty. Trump's Win Gave Them Some.

Novo Nordisk Earnings Ease Investor Concerns, Put Focus on New Obesity Drug Trial

NVO

MT Newswires

15 days ago

Novo Nordisk Earnings Ease Investor Concerns, Put Focus on New Obesity Drug Trial

NVO

Morningstar Research

15 days ago

Analyst Report: Novo Nordisk A/S

NVO

GlobeNewswire

15 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundup

NVO

Quartz

15 days ago

A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundup

NVO

GlobeNewswire

16 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware

NVO

Benzinga

16 days ago

Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware

NVO

Argus Research

16 days ago

October Resets Economic, Interest Rate Expectations

Novo Nordisk Reports Strong Sales Growth in 2024

NVO

TipRanks

16 days ago

Novo Nordisk Reports Strong Sales Growth in 2024

Novo Nordisk's stock hits 9-month low as 2025 guidance underwhelms

NVO

Reuters

16 days ago

Novo Nordisk's stock hits 9-month low as 2025 guidance underwhelms

Novo Nordisk AS (NVO) Q3 2024 Earnings Call Highlights: Robust Sales Growth and Strategic ...

NVO

GuruFocus.com

16 days ago

Novo Nordisk AS (NVO) Q3 2024 Earnings Call Highlights: Robust Sales Growth and Strategic ...

Novo Nordisk Slumps On Tightened Outlook As Wegovy Beats, But Ozempic Lags

NVO

Investor's Business Daily

16 days ago

Novo Nordisk Slumps On Tightened Outlook As Wegovy Beats, But Ozempic Lags

NVO

Morningstar Research

17 days ago

Analyst Report: Novo Nordisk A/S

A new stronger Ozempic is coming. Here's what to know

NVO

Quartz

17 days ago

A new stronger Ozempic is coming. Here's what to know

NVO

MT Newswires

17 days ago

Sector Update: Health Care Stocks Mixed Wednesday Afternoon

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

NVO

Pharmaceutical Technology

17 days ago

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

Strong Wegovy revenue growth for Novo Nordisk but shares dip

NVO

Pharmaceutical Technology

17 days ago

Strong Wegovy revenue growth for Novo Nordisk but shares dip

How to play healthcare stocks on Trump's win

NVO

Yahoo Finance Video

17 days ago

How to play healthcare stocks on Trump's win

Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook

NVO

Yahoo Finance

17 days ago

Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook

Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025

NVO

Investopedia

17 days ago

Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025

Is Novo Nordisk A/S (NVO) The Best European Stock To Buy According to Hedge Funds?

NVO

Insider Monkey

18 days ago

Is Novo Nordisk A/S (NVO) The Best European Stock To Buy According to Hedge Funds?

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

NVO

Zacks

18 days ago

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

Novo Nordisk signs $285m deal with Ascendis to create once-monthly GLP-1RA

NVO

Pharmaceutical Technology

18 days ago

Novo Nordisk signs $285m deal with Ascendis to create once-monthly GLP-1RA

PFE or NVO: Which Is the Better Value Stock Right Now?

NVO

Zacks

18 days ago

PFE or NVO: Which Is the Better Value Stock Right Now?

Hims & Hers will start selling a generic weight loss drug

NVO

Quartz

18 days ago

Hims & Hers will start selling a generic weight loss drug

Novo Nordisk Secures License for Ascendis Pharma's Obesity Drug Technology

NVO

GuruFocus.com

18 days ago

Novo Nordisk Secures License for Ascendis Pharma's Obesity Drug Technology

NVO

GlobeNewswire

18 days ago

Novo Nordisk A/S - share repurchase programme

Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings

NVO

Reuters

18 days ago

Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings

Earnings To Watch: Novo Nordisk AS (OCSE:NOVO B) Reports Q3 2024 Result

NVO

GuruFocus.com

18 days ago

Earnings To Watch: Novo Nordisk AS (OCSE:NOVO B) Reports Q3 2024 Result

Ascendis Pharma granted Novo exclusive worldwide license to TransCon platform

NVO

TipRanks

18 days ago

Ascendis Pharma granted Novo exclusive worldwide license to TransCon platform

Allurion boasts over 17% weight loss with swallowable balloon device

NVO

Medical Device Network

18 days ago

Allurion boasts over 17% weight loss with swallowable balloon device

Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs

NVO

LA Times

18 days ago

Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs

Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.

NVO

Yahoo Finance Video

18 days ago

Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

NVO

Investor's Business Daily

18 days ago

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

What Wall Street Analysts Think of Novo Nordisk's Stock Ahead of Earnings

NVO

Investopedia

18 days ago

What Wall Street Analysts Think of Novo Nordisk's Stock Ahead of Earnings

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat

NVO

Investor's Business Daily

18 days ago

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat

Viking Therapeutics stock falling amid results for new GLP-1 pill

NVO

Yahoo Finance Video

18 days ago

Viking Therapeutics stock falling amid results for new GLP-1 pill

Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug

NVO

Quartz

18 days ago

Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

NVO

Benzinga

19 days ago

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

NVO

MT Newswires

19 days ago

Ascendis, Novo Nordisk to Develop, Commercialize Products in Metabolic, Cardiovascular Diseases

A new weight loss pill outperformed Novo Nordisk's version

NVO

Quartz

19 days ago

A new weight loss pill outperformed Novo Nordisk's version

Viking Therapeutics Slashes Huge Gains On Latest Obesity Drug Data

NVO

Investor's Business Daily

19 days ago

Viking Therapeutics Slashes Huge Gains On Latest Obesity Drug Data

Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?

NVO

Zacks

19 days ago

Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?

Danish town where weight-loss wonder drug Ozempic is made suffers from the highest rates of overweight children in Denmark

NVO

Fortune

19 days ago

Danish town where weight-loss wonder drug Ozempic is made suffers from the highest rates of overweight children in Denmark

NVO

MT Newswires

19 days ago

Market Chatter: Novo Holdings to Receive European Decision on Catalent Acquisition by Dec. 6

Endeveco Bio spin-off to launch obesity trial

NVO

Clinical Trials Arena

19 days ago

Endeveco Bio spin-off to launch obesity trial

Big Pharma’s Obesity Bonanza Faces New Tests

NVO

The Wall Street Journal

19 days ago

Big Pharma’s Obesity Bonanza Faces New Tests

Novo Nordisk reports positive data from part one of semaglutide trial for MASH

NVO

Clinical Trials Arena

19 days ago

Latest Novo Nordisk A/S (NVO) News on November 23, 2024

Share on Social Networks: